within Pharmacolibrary.Drugs.C_CardiovascularSystem.C04A_PeripheralVasodilators.C04AF01_Kallidinogenase;

model Kallidinogenase
  extends Pharmacolibrary.Drugs.ATC.C.C04AF01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>name:</td><td>Kallidinogenase</td></tr><tr><td>ATC code:</td><td>C04AF01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Kallidinogenase is an enzyme derived from animal pancreas, used primarily in certain Asian countries to treat peripheral vascular diseases and cerebrovascular disorders by facilitating vasodilation through the kininâ€“kallikrein system. It is not widely approved or used in the United States or Europe for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for kallidinogenase in humans have not been reported in peer-reviewed publications. The following are estimated parameters based on general enzyme characteristics and dose regimens reported in clinical and therapeutic product information.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial generated model</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Kallidinogenase;
